<DOC>
	<DOCNO>NCT00002485</DOCNO>
	<brief_summary>RATIONALE : Taking part clinical trial may help child cancer receive effective treatment . PURPOSE : Determine patient eligible protocol make available Pediatric Oncology Group enroll , develop strategy increase enrollment clinical trial .</brief_summary>
	<brief_title>Development Strategies Increase Enrollment Clinical Trials Children With Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Identify prospectively physician patient factor associate reason patient eligible Pediatric Oncology Group therapeutic protocol enrol onto study . II . Provide information may use develop intervention strategy decrease barrier patient enrollment , thus increase enrollment therapeutic protocol . OUTLINE : This case-control , multicenter study . Case patient stratify . Stratum 1 comprises patient appropriate Pediatric Oncology Group ( POG ) frontline therapeutic protocol yet submit , disapprove , approve Institutional Review Board ( IRB ) . Stratum 2 comprises patient appropriate POG frontline therapeutic protocol approve IRB . Physicians complete IRB submission form patient stratum 1 . Patients/parents stratum 2 refuse enrollment primary physician complete questionnaire address reason nonenrollment . Control patients/parents consent enrollment complete questionnaire address reason enrollment . Demographic information , include size treat institution annual number patient enrol onto protocol , collect . Additional demographic information regard patient family collect . PROJECTED ACCRUAL : A total 595 case patient ( 12 soft tissue sarcoma , 34 osteosarcoma , 19 brain tumor , 32 Hodgkin 's disease , 60 non-Hodgkin 's lymphoma , 278 acute lymphoblastic leukemia , 65 acute non-lymphoblastic leukemia , 56 neuroblastoma , 14 hepatoblastoma , 25 germ cell tumor ) accrue study within 7 year . Corresponding control patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Case control patient clinically eligible Pediatric Oncology Group ( POG ) frontline therapeutic protocol , whether protocol submit approve physician 's Institutional Review Board Case patient must enrol POG frontline protocol due decision physician patient/parent Control patient must enrol POG frontline protocol Ineligible offer treatment inhouse therapeutic protocol ( institutional review boardapproved ) rather POG protocol PATIENT CHARACTERISTICS : Age : 21 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>localize osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>stage I childhood liver cancer</keyword>
	<keyword>stage II childhood liver cancer</keyword>
	<keyword>stage III childhood liver cancer</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>childhood hepatoblastoma</keyword>
	<keyword>stage I childhood lymphoblastic lymphoma</keyword>
	<keyword>stage II childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III childhood lymphoblastic lymphoma</keyword>
	<keyword>stage IV childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>childhood germ cell tumor</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>extragonadal germ cell tumor</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood meningioma</keyword>
	<keyword>localize unresectable neuroblastoma</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>stage I childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage I childhood large cell lymphoma</keyword>
	<keyword>stage II childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage II childhood large cell lymphoma</keyword>
	<keyword>stage III childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage III childhood large cell lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>untreated childhood visual pathway hypothalamic glioma</keyword>
	<keyword>recurrent childhood visual pathway hypothalamic glioma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
</DOC>